Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-10-22-Speech-2-028"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Medicinal products2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20021022.1.2-028"2
lpv:hasSubsequent	lp_eu:2002-10-22-Speech-2-0292
lpv:speaker	lp:Armonia Bordes2
lpv:spokenAs	member; EUL/NGL (1999-07-20--2004-07-19)3 substitute; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 member; ECON (2002-01-17--2004-07-19)3 member; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees and Delegation for relations with Tadjikistan, Turkmenistan and Mongolia (2002-02-07--2004-07-19)3 member; Committee on Women's Rights and Equal Opportunities (2002-01-17--2004-07-19)3 unknown; Lutte ouvrière (1999-07-20--2004-07-19)3
lpv:translated text	"Mr President, this report is written from the point of view of defending the interests of the pharmaceutical industry. Yet, the quest for profits cannot be reconciled with the defence of public health. When one claims to protect public health, one must put the interests of the community first and one must take into account the health of all human beings, whether or not they can afford to pay. As for the pharmaceutical industry, well, it is only interested in those who can pay. This is the reason why it wants to work quickly, in order to release medicinal products which yield a high return. In other words, in their jargon, they want ‘blockbusters’ which earn more than one billion dollars per year. Spending insufficient time, however, on research and trials in order to rake in profits more quickly will certainly have a detrimental effect on the safety and health of patients, not to mention those working in these industries. I would also like to condemn the other consequence of the quest for profit, namely job losses, including within the research sector. This is what is happening at the moment at the pharmaceutical company, Aventis, which is cutting 10 000 jobs world-wide and closing factories and research centres in several countries. You speak about transparency, but the pharmaceutical industry has always kept its margins under wraps, which are amongst some of the highest in industry, due to the very fact that they are guaranteed by the national health systems. We are told that it would be awful if terrorists were to contaminate populations with smallpox, since we would not have the necessary medicinal products to treat people. Whilst that may be true, this disastrous scenario is already happening. Every day, thousands of children die from diseases that we know how to treat, such as measles, and for which medicinal products exist. It is the thirst for profit of large pharmaceutical companies that is responsible for this, and they enjoy the compelling support of the governments."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph